Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 17Completed 14Unknown 9Terminated 3Not yet recruiting 3Active not recruiting 3Withdrawn 2Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Leukemia, Myeloid, Acute 5Prostatic Neoplasms 4Multiple Myeloma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic HER2-positive Breast Cancer With Brain Metastasis 1Leukemia, Biphenotypic, Acute 1Leukemia 1Insulinoma 1Hyperinsulinism 1Fallopian Tube Neoplasms 1Desmoplastic Small Round Cell Tumor 1Congenital Hyperinsulinism 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Burkitt Lymphoma 1Adenocarcinoma 1

Interventions

Paclitaxel 28Trastuzumab 22Cyclophosphamide 21Doxorubicin 14Docetaxel 14Carboplatin 11exemestane 10Radiotherapy 10Letrozole 10Capecitabine 10pembrolizumab 8Lapatinib 8Fulvestrant 8Neoadjuvant Therapy 6Goserelin 6Bevacizumab 6Anastrozole 6pertuzumab 5palbociclib 5eribulin 5abemaciclib 5Therapeutics 5Magnetic Resonance Spectroscopy 5Epirubicin 5Chemotherapy, Adjuvant 5Aromatase Inhibitors 5tucatinib 4Vinorelbine 4Taxes 4Tamoxifen 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Breast Neoplasms × Injections × Clear all
NCT05634954 2025-10-23

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

GE Healthcare

Phase 1 Withdrawn
Breast

Breast Neoplasms

NCT03121989 2023-03-30

LABC

Sunnybrook Health Sciences Centre

Phase 1 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡